Search

Your search keyword '"Rodriguez, Paulo C."' showing total 568 results
Start Over Author "Rodriguez, Paulo C."
568 results on '"Rodriguez, Paulo C."'

1. Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial

Author

Li, Roger, Villa, Nancy Y., Yu, Xiaoqing, Johnson, Joseph O., Borjas, Gustavo, Dhillon, Jasreman, Moran-Segura, Carlos M., Kim, Youngchul, Francis, Natasha, Dorman, Denise, Powers, John J., Sexton, Wade J., Spiess, Philippe E., Poch, Michael A., Zemp, Logan, Gilbert, Scott M., Zhang, Jingsong, Pow-Sang, Julio M., Anderson, Alexander R. A., Li, Tingyi, Wang, Xuefeng, Grass, G. Daniel, Burke, James M., Dinney, Colin P. N., Rodriguez, Paulo C., Jain, Rohit K., Mulé, James J., and Conejo-Garcia, Jose R.

Published
2024
Full Text
View/download PDF

2. Transgelin 2 guards T cell lipid metabolism and antitumour function

Author

Hwang, Sung-Min, Awasthi, Deepika, Jeong, Jieun, Sandoval, Tito A., Chae, Chang-Suk, Ramos, Yusibeska, Tan, Chen, Marin Falco, Matías, Salvagno, Camilla, Emmanuelli, Alexander, McBain, Ian T., Mishra, Bikash, Ivashkiv, Lionel B., Zamarin, Dmitriy, Cantillo, Evelyn, Chapman-Davis, Eloise, Holcomb, Kevin, Morales, Diana K., Yu, Xiaoqing, Rodriguez, Paulo C., Conejo-Garcia, Jose R., Kaczocha, Martin, Vähärautio, Anna, Song, Minkyung, and Cubillos-Ruiz, Juan R.

Published
2024
Full Text
View/download PDF

6. Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages

Author

Mandula, Jay K., Sierra-Mondragon, Rosa A., Jimenez, Rachel V., Chang, Darwin, Mohamed, Eslam, Chang, Shiun, Vazquez-Martinez, Julio A., Cao, Yu, Anadon, Carmen M., Lee, Sae Bom, Das, Satyajit, Rocha-Munguba, Léo, Pham, Vincent M., Li, Roger, Tarhini, Ahmad A., Furqan, Muhammad, Dalton, William, Churchman, Michelle, Moran-Segura, Carlos M., Nguyen, Jonathan, Perez, Bradford, Kojetin, Douglas J., Obermayer, Alyssa, Yu, Xiaoqing, Chen, Ann, Shaw, Timothy I., Conejo-Garcia, Jose R., and Rodriguez, Paulo C.

Published
2024
Full Text
View/download PDF

7. Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer

Author

Eisa, Nada H., Crowley, Vincent M., Elahi, Asif, Kommalapati, Vamsi Krishna, Serwetnyk, Michael A., Llbiyi, Taoufik, Lu, Sumin, Kainth, Kashish, Jilani, Yasmeen, Marasco, Daniela, El Andaloussi, Abdeljabar, Lee, Sukyeong, Tsai, Francis T.F., Rodriguez, Paulo C., Munn, David, Celis, Esteban, Korkaya, Hasan, Debbab, Abdessamad, Blagg, Brian, and Chadli, Ahmed

Published
2023
Full Text
View/download PDF

8. Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers

Author

Biswas, Subir, Mandal, Gunjan, Anadon, Carmen M., Chaurio, Ricardo A., Lopez-Bailon, Luis U., Nagy, Mate Z., Mine, Jessica A., Hänggi, Kay, Sprenger, Kimberly B., Innamarato, Patrick, Harro, Carly M., Powers, John J., Johnson, Joseph, Fang, Bin, Eysha, Mostafa, Nan, Xiaolin, Li, Roger, Perez, Bradford A., Curiel, Tyler J., Yu, Xiaoqing, Rodriguez, Paulo C., and Conejo-Garcia, Jose R.

Published
2023
Full Text
View/download PDF

11. Increased inflammatory low-density neutrophils in severe obesity and effect of bariatric surgery: Results from case-control and prospective cohort studies

Author

Sanchez-Pino, Maria Dulfary, Richardson, William S., Zabaleta, Jovanny, Puttalingaiah, Ramesh Thylur, Chapple, Andrew G., Liu, Jiao, Kim, Yonghyan, Ponder, Michelle, DeArmitt, Randi, Baiamonte, Lyndsey Buckner, Wyczechowska, Dorota, Zheng, Liqin, Al-Khami, Amir A., Garai, Jone, Martini, Rachel, Davis, Melissa, Gorham, Jessica Koller, Wooldridge, James B., Rodriguez, Paulo C., Miele, Lucio, and Ochoa, Augusto C.

Published
2022
Full Text
View/download PDF

12. BatchFLEX: feature-level equalization of X-batch.

Author

Davis, Joshua T, Obermayer, Alyssa N, Soupir, Alex C, Hesterberg, Rebecca S, Duong, Thac, Yang, Ching-Yao, Dao, Ken Phong, Manley, Brandon J, Grass, G Daniel, Avram, Dorina, Rodriguez, Paulo C, Fridley, Brooke L, Yu, Xiaoqing, Teng, Mingxiang, Wang, Xuefeng, and Shaw, Timothy I

Subjects
GENE expression, SAMPLING (Process), RNA, MOTIVATION (Psychology), MOBILE apps
Abstract

Motivation Integrative analysis of heterogeneous expression data remains challenging due to variations in platform, RNA quality, sample processing, and other unknown technical effects. Selecting the approach for removing unwanted batch effects can be a time-consuming and tedious process, especially for more biologically focused investigators. Results Here, we present BatchFLEX, a Shiny app that can facilitate visualization and correction of batch effects using several established methods. BatchFLEX can visualize the variance contribution of a factor before and after correction. As an example, we have analyzed ImmGen microarray data and enhanced its expression signals that distinguishes each immune cell type. Moreover, our analysis revealed the impact of the batch correction in altering the gene expression rank and single-sample GSEA pathway scores in immune cell types, highlighting the importance of real-time assessment of the batch correction for optimal downstream analysis. Availability and implementation Our tool is available through Github https://github.com/shawlab-moffitt/BATCH-FLEX-ShinyApp with an online example on Shiny.io https://shawlab-moffitt.shinyapps.io/batch_flex/. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. IgA transcytosis and antigen recognition govern ovarian cancer immunity

Author

Biswas, Subir, Mandal, Gunjan, Payne, Kyle K., Anadon, Carmen M., Gatenbee, Chandler D., Chaurio, Ricardo A., Costich, Tara Lee, Moran, Carlos, Harro, Carly M., Rigolizzo, Kristen E., Mine, Jessica A., Trillo-Tinoco, Jimena, Sasamoto, Naoko, Terry, Kathryn L., Marchion, Douglas, Buras, Andrea, Wenham, Robert M., Yu, Xiaoqing, Townsend, Mary K., Tworoger, Shelley S., Rodriguez, Paulo C., Anderson, Alexander R., and Conejo-Garcia, Jose R.

Published
2021
Full Text
View/download PDF

15. MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects

Author

Verma, Vivek, Jafarzadeh, Nazli, Boi, Shannon, Kundu, Subhadip, Jiang, Zhinuo, Fan, Yiping, Lopez, Jose, Nandre, Rahul, Zeng, Peng, Alolaqi, Fatmah, Ahmad, Shamim, Gaur, Pankaj, Barry, Simon T., Valge-Archer, Viia E., Smith, Paul D., Banchereau, Jacques, Mkrtichyan, Mikayel, Youngblood, Benjamin, Rodriguez, Paulo C., Gupta, Seema, and Khleif, Samir N.

Published
2021
Full Text
View/download PDF

19. Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison

Author

Hoogland, Aasha I., primary, Small, Brent J., additional, Oswald, Laura B., additional, Bryant, Crystal, additional, Rodriguez, Yvelise, additional, Gonzalez, Brian D., additional, Li, Xiaoyin, additional, Janelsins, Michelle C., additional, Bulls, Hailey W., additional, James, Brian W., additional, Arboleda, Bianca, additional, Colon-Echevarria, Claudia, additional, Townsend, Mary K., additional, Tworoger, Shelley S., additional, Rodriguez, Paulo C., additional, Bower, Julienne E., additional, Apte, Sachin M., additional, Wenham, Robert M., additional, and Jim, Heather S. L., additional

Published
2023
Full Text
View/download PDF

20. c-Maf: a bad influence in the education of macrophages

Author

Conejo-Garcia, Jose R. and Rodriguez, Paulo C.

Subjects
Macrophages, Tumors -- Development and progression, Beta glucan, Non-small cell lung cancer -- Development and progression, T cells, Transforming growth factors, Small cell lung cancer, Education, Cancer, Immunotherapy, Lung cancer, Health care industry
Abstract

Tumor-associated macrophages (TAMs) represent the most abundant hematopoietic cell type in the solid tumor microenvironment. TAMs drive T cell inhibition, promote angiogenesis, and produce tumor growth factors. Although they can paradoxically exert antitumor activity and prime protective immunity, the pathways driving this phenotype remain unclear. In this issue of theJCI, Liu and colleagues identified the c-Maf transcription factor as a master regulator of protumoral TAM polarization. The authors found that c-Maf promoted TAMs' immunosuppressive activity, governed their metabolic programming, and drove expression of the macrophage differentiation protein, CSF1R. Further, inhibiting c-Maf in myeloid progenitors, and consequent myeloid-lineage cells, including TAMs, delayed tumor growth. Importantly, [beta]-glucan treatment reduced c-MAF expression in macrophages and monocytes from patients with non-small cell lung cancer (NSCLC) where c-MAF is overexpressed. These results reveal mechanisms whereby myeloid cells drive human cancer progression by thwarting protective immunity and could lead to immunotherapy for most solid malignancies., c-Maf upregulation drives M2 attributes and enhances immunosuppressive activity Virtually all solid tumors produce inflammatory factors that pathologically mobilize myeloid cells. At advanced stages of malignant progression, immature cells of [...]

Published
2020
Full Text
View/download PDF

22. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

Author

Rodriguez, Paulo C, Hernandez, Claudia P, Quiceno, David, Dubinett, Steven M, Zabaleta, Jovanny, Ochoa, Juan B, Gilbert, Jill, and Ochoa, Augusto C

Subjects
Prevention, Lung, Biotechnology, Cancer, Development of treatments and therapeutic interventions, Aetiology, 2.1 Biological and endogenous factors, 5.1 Pharmaceuticals, Animals, Arginase, Blotting, Northern, Blotting, Western, Carcinoma, Cell Line, Tumor, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors, Enzyme Induction, Female, Lung Neoplasms, Mice, Mice, Inbred C57BL, Prostaglandins, RNA, Small Interfering, Signal Transduction, T-Lymphocytes, Regulatory, Medical and Health Sciences, Immunology
Abstract

Myeloid suppressor cells (MSCs) producing high levels of arginase I block T cell function by depleting l-arginine in cancer, chronic infections, and trauma patients. In cancer, MSCs infiltrating tumors and in circulation are an important mechanism for tumor evasion and impair the therapeutic potential of cancer immunotherapies. However, the mechanisms that induce arginase I in MSCs in cancer are unknown. Using the 3LL mouse lung carcinoma, we aimed to characterize these mechanisms. Arginase I expression was independent of T cell-produced cytokines. Instead, tumor-derived soluble factors resistant to proteases induced and maintained arginase I expression in MSCs. 3LL tumor cells constitutively express cyclooxygenase (COX)-1 and COX-2 and produce high levels of PGE2. Genetic and pharmacological inhibition of COX-2, but not COX-1, blocked arginase I induction in vitro and in vivo. Signaling through the PGE2 receptor E-prostanoid 4 expressed in MSCs induced arginase I. Furthermore, blocking arginase I expression using COX-2 inhibitors elicited a lymphocyte-mediated antitumor response. These results demonstrate a new pathway of prostaglandin-induced immune dysfunction and provide a novel mechanism that can help explain the cancer prevention effects of COX-2 inhibitors. Furthermore, an addition of arginase I represents a clinical approach to enhance the therapeutic potential of cancer immunotherapies.

Published
2005

23. IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity

Author

Song, Minkyung, Sandoval, Tito A., Chae, Chang-Suk, Chopra, Sahil, Tan, Chen, Rutkowski, Melanie R., Raundhal, Mahesh, Chaurio, Ricardo A., Payne, Kyle K., Konrad, Csaba, Bettigole, Sarah E., Shin, Hee Rae, Crowley, Michael J. P., Cerliani, Juan P., Kossenkov, Andrew V., Motorykin, Ievgen, Zhang, Sheng, Manfredi, Giovanni, Zamarin, Dmitriy, Holcomb, Kevin, Rodriguez, Paulo C., Rabinovich, Gabriel A., Conejo-Garcia, Jose R., Glimcher, Laurie H., and Cubillos-Ruiz, Juan R.

Published
2018
Full Text
View/download PDF

26. Supplementary Figure from TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate

Author

Hesterberg, Rebecca S., primary, Liu, Min, primary, Elmarsafawi, Aya G., primary, Koomen, John M., primary, Welsh, Eric A., primary, Hesterberg, Stephen G., primary, Ranatunga, Sujeewa, primary, Yang, Chunying, primary, Li, Weimin, primary, Lawrence, Harshani R., primary, Rodriguez, Paulo C., primary, Berglund, Anders E., primary, and Cleveland, John L., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Table from Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma

Author

Song, Xiaofei, primary, Chang, Shiun, primary, Seminario-Vidal, Lucia, primary, de Mingo Pulido, Alvaro, primary, Tordesillas, Leticia, primary, Song, Xingzhi, primary, Reed, Rhianna A., primary, Harkins, Andrea, primary, Whiddon, Shannen, primary, Nguyen, Jonathan V., primary, Segura, Carlos Moran, primary, Zhang, Chaomei, primary, Yoder, Sean, primary, Sayegh, Zena, primary, Zhao, Yun, primary, Messina, Jane L., primary, Harro, Carly M., primary, Zhang, Xiaohui, primary, Conejo-Garcia, José R., primary, Berglund, Anders, primary, Sokol, Lubomir, primary, Zhang, Jianhua, primary, Rodriguez, Paulo C., primary, Mulé, James J., primary, Futreal, Andrew P., primary, Tsai, Kenneth Y., primary, and Chen, Pei-Ling, primary

Published
2023
Full Text
View/download PDF

28. Data from Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine

Author

Basu, Amrita, primary, Albert, Gabriella K., primary, Awshah, Sabrina, primary, Datta, Jashodeep, primary, Kodumudi, Krithika N., primary, Gallen, Corey, primary, Beyer, Amber, primary, Smalley, Keiran S.M., primary, Rodriguez, Paulo C., primary, Duckett, Derek R., primary, Forsyth, Peter A., primary, Soyano, Aixa, primary, Koski, Gary K., primary, Lima Barros Costa, Ricardo, primary, Han, Heather, primary, Soliman, Hatem, primary, Lee, Marie Catherine, primary, Kalinski, Pawel, primary, and Czerniecki, Brian J., primary

Published
2023
Full Text
View/download PDF

29. Data from TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate

Author

Hesterberg, Rebecca S., primary, Liu, Min, primary, Elmarsafawi, Aya G., primary, Koomen, John M., primary, Welsh, Eric A., primary, Hesterberg, Stephen G., primary, Ranatunga, Sujeewa, primary, Yang, Chunying, primary, Li, Weimin, primary, Lawrence, Harshani R., primary, Rodriguez, Paulo C., primary, Berglund, Anders E., primary, and Cleveland, John L., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Data from Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine

Author

Basu, Amrita, primary, Albert, Gabriella K., primary, Awshah, Sabrina, primary, Datta, Jashodeep, primary, Kodumudi, Krithika N., primary, Gallen, Corey, primary, Beyer, Amber, primary, Smalley, Keiran S.M., primary, Rodriguez, Paulo C., primary, Duckett, Derek R., primary, Forsyth, Peter A., primary, Soyano, Aixa, primary, Koski, Gary K., primary, Lima Barros Costa, Ricardo, primary, Han, Heather, primary, Soliman, Hatem, primary, Lee, Marie Catherine, primary, Kalinski, Pawel, primary, and Czerniecki, Brian J., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Table from TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate

Author

Hesterberg, Rebecca S., primary, Liu, Min, primary, Elmarsafawi, Aya G., primary, Koomen, John M., primary, Welsh, Eric A., primary, Hesterberg, Stephen G., primary, Ranatunga, Sujeewa, primary, Yang, Chunying, primary, Li, Weimin, primary, Lawrence, Harshani R., primary, Rodriguez, Paulo C., primary, Berglund, Anders E., primary, and Cleveland, John L., primary

Published
2023
Full Text
View/download PDF

32. Data from Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Author

Phadke, Manali S., primary, Chen, Zhihua, primary, Li, Jiannong, primary, Mohamed, Eslam, primary, Davies, Michael A., primary, Smalley, Inna, primary, Duckett, Derek R., primary, Palve, Vinayak, primary, Czerniecki, Brian J., primary, Forsyth, Peter A., primary, Noyes, David, primary, Adeegbe, Dennis O., primary, Eroglu, Zeynep, primary, Nguyen, Kimberly T., primary, Tsai, Kenneth Y., primary, Rix, Uwe, primary, Burd, Christin E., primary, Chen, Yian A., primary, Rodriguez, Paulo C., primary, and Smalley, Keiran S.M., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figures and Table from Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Author

Phadke, Manali S., primary, Chen, Zhihua, primary, Li, Jiannong, primary, Mohamed, Eslam, primary, Davies, Michael A., primary, Smalley, Inna, primary, Duckett, Derek R., primary, Palve, Vinayak, primary, Czerniecki, Brian J., primary, Forsyth, Peter A., primary, Noyes, David, primary, Adeegbe, Dennis O., primary, Eroglu, Zeynep, primary, Nguyen, Kimberly T., primary, Tsai, Kenneth Y., primary, Rix, Uwe, primary, Burd, Christin E., primary, Chen, Yian A., primary, Rodriguez, Paulo C., primary, and Smalley, Keiran S.M., primary

Published
2023
Full Text
View/download PDF

35. Abstract 5703: The immune cell state atlas analysis predicts therapeutic benefits with immune checkpoint inhibitors

Author

Li, Tingyi, primary, Sukrithan, Vineeth, additional, Ratan, Aakrosh, additional, McCarter, Martin, additional, Carpten, John, additional, Colman, Howard, additional, Ikeguchi, Alexandra P., additional, Wang, Xuefeng, additional, Puzanov, Igor, additional, Dalton, Susanne, additional, Churchman, Michelle, additional, Hwu, Patrick, additional, Rodriguez, Paulo C., additional, Dalton, William S., additional, Weiner, George J., additional, and Tarhini, Ahmad, additional

Published
2023
Full Text
View/download PDF

36. Data from Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma

Author

Song, Xiaofei, primary, Chang, Shiun, primary, Seminario-Vidal, Lucia, primary, de Mingo Pulido, Alvaro, primary, Tordesillas, Leticia, primary, Song, Xingzhi, primary, Reed, Rhianna A., primary, Harkins, Andrea, primary, Whiddon, Shannen, primary, Nguyen, Jonathan V., primary, Segura, Carlos Moran, primary, Zhang, Chaomei, primary, Yoder, Sean, primary, Sayegh, Zena, primary, Zhao, Yun, primary, Messina, Jane L., primary, Harro, Carly M., primary, Zhang, Xiaohui, primary, Conejo-Garcia, José R., primary, Berglund, Anders, primary, Sokol, Lubomir, primary, Zhang, Jianhua, primary, Rodriguez, Paulo C., primary, Mulé, James J., primary, Futreal, Andrew P., primary, Tsai, Kenneth Y., primary, and Chen, Pei-Ling, primary

Published
2023
Full Text
View/download PDF

38. Supplemental Figure 2 from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

Author

Hossain, Fokhrul, primary, Al-Khami, Amir A., primary, Wyczechowska, Dorota, primary, Hernandez, Claudia, primary, Zheng, Liqin, primary, Reiss, Krzystoff, primary, Valle, Luis Del, primary, Trillo-Tinoco, Jimena, primary, Maj, Tomasz, primary, Zou, Weiping, primary, Rodriguez, Paulo C., primary, and Ochoa, Augusto C., primary

Published
2023
Full Text
View/download PDF

42. Supplemental Figure 4 from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

Author

Hossain, Fokhrul, primary, Al-Khami, Amir A., primary, Wyczechowska, Dorota, primary, Hernandez, Claudia, primary, Zheng, Liqin, primary, Reiss, Krzystoff, primary, Valle, Luis Del, primary, Trillo-Tinoco, Jimena, primary, Maj, Tomasz, primary, Zou, Weiping, primary, Rodriguez, Paulo C., primary, and Ochoa, Augusto C., primary

Published
2023
Full Text
View/download PDF

43. Supplemenatl Figure 6 from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

Author

Hossain, Fokhrul, primary, Al-Khami, Amir A., primary, Wyczechowska, Dorota, primary, Hernandez, Claudia, primary, Zheng, Liqin, primary, Reiss, Krzystoff, primary, Valle, Luis Del, primary, Trillo-Tinoco, Jimena, primary, Maj, Tomasz, primary, Zou, Weiping, primary, Rodriguez, Paulo C., primary, and Ochoa, Augusto C., primary

Published
2023
Full Text
View/download PDF

45. Supplemental Figure 3 from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

Author

Hossain, Fokhrul, primary, Al-Khami, Amir A., primary, Wyczechowska, Dorota, primary, Hernandez, Claudia, primary, Zheng, Liqin, primary, Reiss, Krzystoff, primary, Valle, Luis Del, primary, Trillo-Tinoco, Jimena, primary, Maj, Tomasz, primary, Zou, Weiping, primary, Rodriguez, Paulo C., primary, and Ochoa, Augusto C., primary

Published
2023
Full Text
View/download PDF

46. Supplemental Figure Legends from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

Author

Hossain, Fokhrul, primary, Al-Khami, Amir A., primary, Wyczechowska, Dorota, primary, Hernandez, Claudia, primary, Zheng, Liqin, primary, Reiss, Krzystoff, primary, Valle, Luis Del, primary, Trillo-Tinoco, Jimena, primary, Maj, Tomasz, primary, Zou, Weiping, primary, Rodriguez, Paulo C., primary, and Ochoa, Augusto C., primary

Published
2023
Full Text
View/download PDF

47. Data from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

Author

Hossain, Fokhrul, primary, Al-Khami, Amir A., primary, Wyczechowska, Dorota, primary, Hernandez, Claudia, primary, Zheng, Liqin, primary, Reiss, Krzystoff, primary, Valle, Luis Del, primary, Trillo-Tinoco, Jimena, primary, Maj, Tomasz, primary, Zou, Weiping, primary, Rodriguez, Paulo C., primary, and Ochoa, Augusto C., primary

Published
2023
Full Text
View/download PDF

48. Supplemental Figure 1 from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

Author

Hossain, Fokhrul, primary, Al-Khami, Amir A., primary, Wyczechowska, Dorota, primary, Hernandez, Claudia, primary, Zheng, Liqin, primary, Reiss, Krzystoff, primary, Valle, Luis Del, primary, Trillo-Tinoco, Jimena, primary, Maj, Tomasz, primary, Zou, Weiping, primary, Rodriguez, Paulo C., primary, and Ochoa, Augusto C., primary

Published
2023
Full Text
View/download PDF

49. Supplemental Figure 5 from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

Author

Hossain, Fokhrul, primary, Al-Khami, Amir A., primary, Wyczechowska, Dorota, primary, Hernandez, Claudia, primary, Zheng, Liqin, primary, Reiss, Krzystoff, primary, Valle, Luis Del, primary, Trillo-Tinoco, Jimena, primary, Maj, Tomasz, primary, Zou, Weiping, primary, Rodriguez, Paulo C., primary, and Ochoa, Augusto C., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results